Balana, C., Sepulveda, J., Pineda, E., Vaz, M., Mesia, C., Fuster, J., . . . Del Barco, S. (2019). P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL. Neuro Oncol.
シカゴスタイル引用形Balana, C., et al. "P14.58 Extending Adjuvant Temozolomide Longer Than Six Cycles Doesn’t Add Any Benefit to Glioblastoma Patients According to the Randomized GEINO-014 TRIAL." Neuro Oncol 2019.
MLA引用形式Balana, C., et al. "P14.58 Extending Adjuvant Temozolomide Longer Than Six Cycles Doesn’t Add Any Benefit to Glioblastoma Patients According to the Randomized GEINO-014 TRIAL." Neuro Oncol 2019.
警告: この引用は必ずしも正確ではありません.